Loading clinical trials...
Loading clinical trials...
Randomized Trial of Tenecteplase to Treat Severe Submassive Pulmonary Embolism
Conditions
Interventions
Tenecteplase + Enoxaparin
0.9% Saline + Enoxaparin
Locations
7
United States
University of California, Davis Medical Center
Sacramento, California, United States
University of Colorado Hospital
Aurora, Colorado, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Carolinas Medical Center
Charlotte, North Carolina, United States
Rhode Island Hospital
Providence, Rhode Island, United States
Start Date
May 1, 2008
Primary Completion Date
May 1, 2012
Completion Date
October 1, 2012
Last Updated
October 12, 2022
NCT06183944
NCT06189313
NCT06357403
NCT06451003
NCT06480994
NCT06954727
Lead Sponsor
Wake Forest University Health Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions